SAN GERONIMO, Calif., Dec. 13, 2011 (GLOBE NEWSWIRE) -- Virogen, Inc. (OTC:VRNI), a holding company specializing in data security and encryption technology, today announced that the company has been granted eligibility status by the Depository Trust Corporation (DTC).
DTC eligibility allows ownership of the company's shares to be transferred electronically by the DTC. The Depository Trust Company is a member of the U.S. Federal Reserve System and a registered clearing agency with the Securities and Exchange Commission (SEC). The DTC provides a safe and efficient way for buyers and sellers of securities to execute and settle transactions.
Virogen, Inc.'s common shares trade on the Over the Counter (OTC) market under the ticker symbol "VRNI" and may be bought and sold through brokerages such as E-Trade, Scottrade, and TD Ameritrade.
"We are very excited to have received DTC eligibility. This is a key milestone for the company and a major step in increasing our exposure in the investment community," commented Paul Hogan, CEO of Virogen, Inc. "Now Virogen can move forward with its plans to market our subsidiary T3's proprietary network and database security technology to large enterprises consisting of Fortune 500 clients and other large companies."
About Virogen, Inc.
Virogen, Inc. is a technology holding company. The company's wholly owned subsidiary, Tiger Team Technologies "T3," has developed a very unique suite of copyrighted tools to address the network and database security needs of enterprise level companies and corporations. T3's risk management offering provides an unprecedented level of security and liability protection, positioning it as the only company with a comprehensive solution to data security breaches for its clients. T3's primary markets include medical service providers, financial services firms, brokerages and currency transaction platforms, consumer credit card companies, banking entities, retailers, defense and government related operations.
Forward-Looking Statements:
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Virogen, Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.